@DrMSDatoo

Infectious Diseases/Microbiology Clinical Lecturer @UniofOxford @JennerInstitute. Views my own.

Joined April 2021
  • Tweets11
  • Following108
  • Followers113
The phase II results of our malaria vaccine demonstrating 77% efficacy can now be found in the Lancet @HalTinto @ProfKatieEwer thelancet.com/journals/lance…

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal adminis...

R21/MM appears safe and very immunogenic in African children, and shows promising high-level efficacy.

thelancet.com
1
3
1
24
NEW: Oxford R21 malaria vaccine receives @WHO recommendation paving the way for global roll-out. The vaccine developed by Oxford & @SerumInstIndia demonstrates a high efficacy. The jab could reduce over half a million malaria-related deaths annually. #OxfordVaccine

64
366
93
929
289,769
Our malaria vaccine - co-developed with @SerumInstIndia - can be manufactured at mass scale and modest cost, enabling as many as 100s of millions of doses to be supplied to African countries which are suffering a significant malaria burden. #OxfordVaccine ox.ac.uk/news/2023-10-02-oxf…

Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global...

The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant is critical to reducing over half a million malaria-related deaths...

ox.ac.uk
8
21
5,677
'The goal is to completely eradicate malaria.' The researchers behind Oxford's malaria vaccine share why the jab could be a potential game-changer in Africa. #OxfordVaccine

Malaria: The devil we know

3
27
4
102
17,470
Thank you to @IDJClub and @Boghuma for choosing to review our paper this week
ID Journal Club@IDJClub25 May 2021
Once again here is the visual abstract highlighting the salient points of this study in case you missed it at the start. Hope you enjoyed the @IDJClub first tropical medicine paper😊. It was my pleasure moderating tonight's lively discussions! #IDJClub
3
Our promising phase III R21/MM malaria vaccine starts in Mali
University of Oxford
@UniofOxford7 May 2021
ℹ️ | Malaria vaccine update First vaccinations have now begun in Mali in a phase III trial of a malaria vaccine developed at @UniofOxford. It is hoped that this phase III trial will help lead to licensure of the vaccine by 2023. More info ⬇️

4
NEW: Oxford researchers find malaria vaccine is highly effective: • Vaccine efficacy of 77% in African children • Vaccine, trialled in 450 children, shows favourable safety profile and was well-tolerated More info ⬇️ bit.ly/3dP47fH

135
3,518
1,471
11,610
Today is #WorldMalariaDay. We are excited to be starting large-scale safety and efficacy trials across four African countries, in 4,800 children aged 5-36 months.
University of Oxford
@UniofOxford23 Apr 2021
NEW: Oxford researchers find malaria vaccine is highly effective: • Vaccine efficacy of 77% in African children • Vaccine, trialled in 450 children, shows favourable safety profile and was well-tolerated More info ⬇️ bit.ly/3dP47fH

1
5
2
30
In 2017 @WHO launched the E-2020 initiative to support 21 countries in their efforts to get to zero #malaria cases by 2020. Today we report on the progress and the exciting addition of a new group of 25 countries w/the potential to #EndMalaria by 2025. 📢bit.ly/3emDcGS
2
35
60
Amazing results from a Phase 2 study of #R21 the #malaria #vaccine I made in the lab 8 years ago! 77% efficacy! So proud to have played a part. Huge congratulations to the whole team who made this happen @JennerInstitute @HalTinto @DrMSDatoo @SerumInstIndia @ProfKatieEwer
This quoted post is unavailable.
Try viewing anyway · View on X
13
61
9
264
Our exciting malaria vaccine results from Burkina Faso @HalTinto @ProfKatieEwer @Kat_a_Collins @JennerInstitute @SerumInstIndia @Novavax papers.ssrn.com/sol3/papers.…
1
8
Load more